CAS: 83150-76-9 - Octreotide acetate

Fórmula: C₄₉H₆₆N₁₀O₁₀S₂・2(C₂H₄O₂)

InChI: InChI=1/C49H66N10O10S2.C2H4O2/c1-28(61)39(25-60)56-48(68)41-27-71-70-26-40(57-43(63)34(51)21-30-13-5-3-6-14-30)47(67)54-37(22-31-15-7-4-8-16-31)45(65)55-38(23-32-24-52-35-18-10-9-17-33(32)35)46(66)53-36(19-11-12-20-50)44(64)59-42(29(2)62)49(69)58-41;1-2(3)4/h3-10,13-18,24,28-29,34,36-42,52,60-62H,11-12,19-23,25-27,50-51H2,1-2H3,(H,53,66)(H,54,67)(H,55,65)(H,56,68)(H,57,63)(H,58,69)(H,59,64);1H3,(H,3,4)/t28-,29-,34-,36+,37+,38-,39-,40+,41+,42+;/m1./s1

Sinónimos:

• L-cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl) propyl)-cyclic (2->7)-disulfide, (R-(R*,R*))
• OctreotideAcetate
• 10-(4-aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate (1:2)
• (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(D-phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
• (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(D-phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
• 1: PN: EP1118336 SEQID: 1 claimed protein
• 11: PN: US20030229017 PAGE: 13 claimed protein
• 14: PN: DE10147056 PAGE: 40 claimed protein
• 17: PN: US6268342 SEQID: 18 claimed protein
• 25: PN: WO2007081792 SEQID: 40 claimed protein
• L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide
• Longastatin
• Octreotide
• Sms 201-995

Octreotide

CAS: 83150-76-9

A slow-release form of octreotide. Pamoate is the bivalent anion of pamoic acid (embonic acid, …

• Fórmula: C₄₉H₆₆N₁₀O₁₀S₂
• Pureza: > 98%
• Peso molecular: 1019.26

[R-(R*,R*)]-D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxy-methyl)propyl]-cysteinamide cyclic(2→7)-disulfide

CAS: 83150-76-9

• Fórmula: C₄₉H₆₆N₁₀O₁₀S₂
• Pureza: 98%;RG
• Forma y color: Solid
• Peso molecular: 1019.2393

Octreotide

CAS: 83150-76-9

• Fórmula: C₄₉H₆₆N₁₀O₁₀S₂
• Peso molecular: 1019.24

Octreotide

CAS: 83150-76-9

Octreotide (SMS 201-995) is a potent inhibitor of growth hormone, glucagon, and insulin.

• Fórmula: C₄₉H₆₆N₁₀O₁₀S₂
• Pureza: 99.64%
• Forma y color: White Powder
• Peso molecular: 1019.24

Octreotide Diacetate

CAS: 622838-44-2 83150-76-9

• Fórmula: C₄₉H₆₆N₁₀O₁₀S₂C₂H₄O₂
• Forma y color: White To Off-White Solid
• Peso molecular: 1019.25 2*60.05

13C6-Lys Octreotide Trifluoroacetate

CAS: 83150-76-9

• Fórmula: C₄₃C₆H₆₆N₁₀O₁₀S₂•xCHF₃O₂
• Forma y color: White to Off-White Solid
• Peso molecular: 1025.2011402

Octreotide-phenylalanine-d8 di-Trifluoroacetic Acid Salt

CAS: 83150-76-9

Applications Labelled octapeptide analog of Somatostatin. A gastric antisecretory agent. Used in treatment of acromegaly. …

• Fórmula: C₅₃H₆₀D₈F₆N₁₀O₁₄S₂
• Forma y color: White to Off-White Solid
• Peso molecular: 1255.34

Octreotide

CAS: 83150-76-9

Octreotide is a drug that belongs to the macrocycle class of polymers. It is used …

• Fórmula: C₄₉H₆₆N₁₀O₁₀S₂
• Pureza: Min. 95%
• Peso molecular: 1,019.24 g/mol

Octreotide

CAS: 83150-76-9

Octreotide is a synthetic somatostatin analogue used for the treatment of acromegaly and neuroendocrine tumours. …

• Peso molecular: 1,018.4 g/mol

Octreotide

CAS: 83150-76-9

Octreotide is a drug that is used to treat carcinoid syndrome, a condition characterized by …

• Fórmula: C₄₉H₆₆N₁₀O₁₀S₂
• Pureza: Min. 95%
• Peso molecular: 1,019.24 g/mol